Systemic sclerosis (scleroderma): open trials in Italy

• NCT05878717

  A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  Trial Treatment · Phase 2/3 · GlaxoSmithKline

  Azienda Ospedaliero-Universitaria delle Marche, Ancona · University Hospital Consorziale Policlinico, Bari · Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania, Catania · University Hospital Of Ferrara, Ferrara · Careggi University Hospital, Florence · Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto, Milan · Azienda Ospedaliero - Universitaria di Modena, Modena · Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Naples · Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano · Azienda Ospedale Universita Padova, Padova · Fondazione IRCCS Policlinico San Matteo, Pavia · Azienda Ospealiero Universitaria Policlinico Umberto I, Rome · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Azienda Ospedaliera Universitaria Integrata Verona, Verona

  Registry updated 2026-09-08

• NCT06195072

  Platform Clinical Study for Conquering Scleroderma

  Trial Treatment · Phase 2 · Scleroderma Research Foundation, Inc.

  Azienda Ospedaliero-Universitaria delle Marche, Ancona · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia · Careggi University Hospital, Florence · Ospedale San Raffaele S.r.l., Milan · Azienda Ospedaliero - Universitaria di Modena, Modena · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

  Registry updated 2026-08-18

• NCT06991114

  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.

  Artiva Investigational Site Brescia, Brescia

  Registry updated 2026-07-31

• NCT07642297

  TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

  Research · Fondazione Policlinico Universitario Campus Bio-Medico

  Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome

  Registry updated 2026-06-11

• NCT07348263

  EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

  Research · Meyer Children's Hospital IRCCS

  Meyer Children's Hospital IRCCS, Florence · IRCCS Giannina Gaslini, Genova · Università di Udine, Udine

  Registry updated 2026-03-11

All Systemic sclerosis (scleroderma) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error